Bibliographic Info
GuidelineUpdated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics.
Year of Publication2022
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
We recommend treatment using pangenotypic DAA regimens for all adolescents (12–17 years) with chronic hepatitis C infection, regardless of stage of disease
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Updated recommendations on treatment of adolescents and children with chronic HCV infection: policy brief.
Year2022
InstitutionWorld Health Organization